タイトル:

出版社:

ISBN:

著者:

キーワード:

カテゴリー:

発行年:

～

検索条件をクリア

書籍詳細

未契約

書籍名	先進医療NAVIGATOR 今日の再生医療・細胞医療の産業化に向けて
出版社	日本医学出版ヘルスケア・アカデミー
発行日	2017-07-10
著者	先進医療フォーラム(編集)
ISBN	9784865770254
ページ数	140
版刷巻号	初版第1刷
分野	臨床医学：一般臨床医学一般
閲覧制限	未契約

本書では特に進歩の著しい再生医療・細胞医療の産業化を取り上げた。第1章では斯界の専門家を結集し、再生医療・細胞医療の研究最前線としてまとめ、第2章では神奈川県と神戸市の再生医療・細胞医療の産業化の最前線を行政、企業側の動向を取り上げ具体的に解説した。

目次

表紙
閲覧
巻頭言
iii閲覧
執筆者一覧
iv閲覧
目次
v閲覧
第1章再生医療・細胞医療の研究最前線
P.1閲覧
- 1 再生医療の最前線～重症心不全に対する心筋再生治療法の開発～
- 2 iPS細胞研究最前線
- 3 ティッシュ・エンジニアリング研究最前線
- 4 再生医療・細胞医療産業の最前線 ( 総論 )
第2章再生・細胞医療産業の最前線
P.18閲覧
- 1 神戸医療産業都市における再生医療分野の事業化に向けて
- 2 公益財団法人先端医療振興財団・細胞療法研究開発センターの取り組み
- 3 神戸医療産業都市の企業の取り組み
- 4 再生・細胞医療の産業化に向けた神奈川県の戦略
- 5 ライフイノベーションセンター ( LIC ) 入居企業の取り組み
第3章特別寄稿 : 再生医療・細胞医療への期待
P.52閲覧
- 1 ヘルスケア・ニューフロンティアの実現に向けて～その先に描く人生百歳時代の設計図～
- 2 神戸医療産業都市の取り組み
第4章企業紹介
P.56閲覧
- 再生医療の研究開発・製造環境の革新を目指す「セラボ殿町」のご紹介
第5章先進医療の各技術の概要
P.60閲覧
- 1 先進医療の概要
- 2 先進医療の各技術の概要
- 3 先進医療を実施している医療機関一覧
奥付
閲覧

参考文献

第1章再生医療・細胞医療の研究最前線

P.5 掲載の参考文献

1) Memon IA, Sawa Y, Miyagawa S, Taketani S, Matsuda H. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy. J Thorac Cardiovasc Surg.
pubmed

2) Fujita T, Sakaguchi T, Miyagawa S, Saito A, Sekiya N, Izutani H, et al. Clinical impact of combined transplantation of autologous skeletal myoblasts and bone marrow mononuclear cells in patients with severely deteriorated ischemic cardiomyopathy. Surg Today. 2011 ; 41 (8) : 1029-36.
pubmed

3) Miyagawa S, Matsumiya G, Funatsu T, Yoshitatsu M, Sekiya N, Fukui S, et al. Combined autologous cellular cardiomyoplasty using skeletal myoblasts and bone marrow cells for human ischemic cardiomyopathy with left ventricular assist system implantation : report of a case. Surg Today. 2009 ; 39 (2) : 133-6.
pubmed

4) Shimizu T, Yamato M, Kikuchi A, Okano T. Two-dimensional manipulation of cardiac myocyte sheets utilizing temperature-responsive culture dishes augments the pulsatile amplitude. Tissue engineering. 2001 ; 7 (2) : 141-51.
pubmed

5) Miyagawa S, Sawa Y, Sakakida S, Taketani S, Kondoh H, Memon IA, et al. Tissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium : their integration with recipient myocardium. Transplantation. 2005 ; 80 (11) : 1586-95.
pubmed

6) Memon IA, Sawa Y, Fukushima N, Matsumiya G, Miyagawa S, Taketani S, et al. Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J Thorac Cardiovasc Surg. 2005 ; 130 (5) : 1333-41.

7) Kondoh H, Sawa Y, Miyagawa S, Sakakida-Kitagawa S, Memon IA, Kawaguchi N, et al. Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters. Cardiovasc Res. 2006 ; 69 (2) : 466-75.
pubmed

8) Hata H, Matsumiya G, Miyagawa S, Kondoh H, Kawaguchi N, Matsuura N, et al. Grafted skeletal myoblast sheets attenuate myocardial remodeling in pacing-induced canine heart failure model. J Thorac Cardiovasc Surg. 2006 ; 132 (4) : 918-24.

9) Miyagawa S, Saito A, Sakaguchi T, Yoshikawa Y, Yamauchi T, Imanishi Y, et al. Impaired Myocardium Regeneration With Skeletal Cell Sheets-A Preclinical Trial for Tissue-Engineered Regeneration Therapy. Transplantation. 2010 ; 90 (4) : 364-72 10.1097/TP.0b013e3181e6f201.

10) Shudo Y, Miyagawa S, Fukushima S, Saito A, Kawaguchi N, Matsuura N, et al. Establishing new porcine ischemic cardiomyopathy model by transcatheter ischemiareperfusion of the entire left coronary artery system for preclinical experimental studies. Transplantation. 2011 ; 92 (7) : e34-5.

11) Hoashi T, Matsumiya G, Miyagawa S, Ichikawa H, Ueno T, Ono M, et al. Skeletal myoblast sheet transplantation improves the diastolic function of a pressure-overloaded right heart. J Thorac Cardiovasc Surg. 2009 ; 138 (2) : 460-7.

12) Saito S, Miyagawa S, Sakaguchi T, Imanishi Y, Iseoka H, Nishi H, et al. Myoblast sheet can prevent the impairment of cardiac diastolic function and late remodeling after left ventricular restoration in ischemic cardiomyopathy. Transplantation. 2012 ; 93 (11) : 1108-15.
pubmed

13) Uchinaka A, Kawaguchi N, Hamada Y, Miyagawa S, Saito A, Mori S, et al. Transplantation of elastin-secreting myoblast sheets improves cardiac function in infarcted rat heart. Molecular and cellular biochemistry. 2012 ; 368 (1-2) : 203. 14.

14) Sekiya N, Matsumiya G, Miyagawa S, Saito A, Shimizu T, Okano T, et al. Layered implantation of myoblast sheets attenuates adverse cardiac remodeling of the infarcted heart. J Thorac Cardiovasc Surg, 2009 ; 138 (4) : 985-93.

15) Sawa Y, Miyagawa S, Sakaguchi T, Fujita T, Matsuyama A, Saito A, et al. Tissue engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with DCM : report of a case. Surg Today. 42 (2) : 181-4.

16) Sawa Y, Yoshikawa Y, Toda K, Fukushirna S, Yamazaki K, Ono M, et al. Safety and Efficacy of Autologoし1s Skeletal Myoblast Sheets (TCD-51073) for the Treatment of Severe Chronic Heart Failure Due to Ischemic Heart Disease. Circulation journal : official journal of the Japanese Circulation Society. 2015 ; 79 (5) : 991-9.

P.10 掲載の参考文献

1) Takahashi, K. et al : Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872. 2007.
pubmed

2) Yu, J. et al : Induced pluripotent stem cell lines derived from human somatic cells. Science (New York, N. Y.) 318, 1917-1920, 2007.

3) Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. 2006.
pubmed

4) Okita, K, Nakagawa, M., Hyenjong, H., Ichisaka, T. & Yamanaka, S. Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors. Science (New York, N. Y.) 322, 949-953, doi : 1164270 [pii] 10.1126/science. 1164270. 2008.

5) Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G. & Hochedlinger, K. Induced Pluripotent Stem Cells Generated Without Viral Integration. Science (New York, N. Y. ) 322, 945-949, doi : 1162494 [pii] 10.1126/science. 1162494. 2008.

6) Yu, J. et al : Human induced pluripotent stem cells free of vector and transgene sequences. Science (New York, N. Y.) 324, 797-801, doi : 1172482 [pii] 10.1126/science. 1172482. 2009.

7) Zhou, W. & Freed, C. R. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 27, 2667-2674, doi : 10.1002/stem. 201. 2009.

8) Fusaki, N., Ban, H., Nishiyama, A., Saeki, K. & Hasegawa, M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad ser B Phys Biol Sci 85, 348-362, doi : JST. JSTAGE/pjab/85.348 [pii]. 2009.
pubmed

9) Okita, K. et al. A more efficient method to generate integration-free human iPS cells. Nat Methods 8, 409-412, doi : nmeth. 1591 [pii] 10.1038/nmeth. 1591. 2011.

10) Jia, F. et al : A nonviral minicircle vector for deriving human iPS cells. Nature thods 7, 197-199, doi : nmeth. 1426 [pii] 10.1038/nmeth. 1426. 2010.

11) Zhou, H. et al : Generation of induced pluripotent stem cells using recombinant proteins. Cell stem cell 4, 381-384, doi : Sl934-5909 (09) 00159-3 [pii] 10.1016/j. stem. 2009. 04. 005. 2009.

12) Warren, L. et al : Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cellstem cell 7, 618-630, doi : 10,1016/j. stem. 2010. 08. 012. 2010.

13) Haase, A. et al : Generation of induced pluripotent stem cells from human cord blood. Cell stem cell, 434-441, doi : S1934-5909 (09) 00445-7 [pii] 101016/j. stem. 2009. 08. 021. 2009.

14) Ye, Z. et al. Human-induced pluripotent stem cells from blood. cells of healthy donors and patients with acquired blood disorders. Blood 114, 5473-5480, doi : 10. 1182/blood-2009-04-217406. 2009.

15) Thomson, J. A. et al : Embryonic stem cell lines derived from human blastocysts. Science (New York, N. Y.) 282, 1145-1147. 1998.

16) Xu, C. et al : Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 19, 971974. 2001.

17) Chen, G. et al : Chemically defined conditions for human iPSC derivation and culture. Nat Methods 8, 424-429, doi : 10.1038/nmeth. 1593. 2011.

18) Miyazaki, T. et al : Laminin E8 fragments support efficient adhesion and expansion of dissociated human pluripotent stem celis. Nat Commun 3, 1236, doi : 10.1038/nconlrns2231. 2012.

19) Nakagawa, M. et al. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci Rep 4, 3594, doi : 10.1038/srepO3594. 2014.

20) Watanabe, K. et al : AROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 25, 681-686, doi : 10.1038/nbt1310. 2007.

21) Nakajima, F., Tokunaga, K. & Nakatsuji, N. HLA Matching Estimations in a Hypothetical Bank of Human Embryonic Stem Cell Lines in the Japanese Population for Use in Cell Transplantation Therapy. Stem Cells. 2006.

22) Nakatsuji, N., Nakajima, F. & Tokunaga, K. HLA-haplotype banking and iPS cells. Nat Biotechnol 26, 739-740, doi : nbtO708-739 [pii] 10.1038/nbt0708-739. 2008.

23) Jinek, M. et al : A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial irnmunity. Science (New York, N. Y.) 337, 816-821, doi : 10.1126/science. 1225829. 2012.

24) Qi, L. S. et al : Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152, 1173-1183, doi : 10.1016/j.cell.2013.02.022. 2013.

25) Larson, M. H. et al : CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nature protocols 8, 2180-2196, doi : 10.1038/nprot.2013.132. 2013.

26) Mandegar, M. A. et al : CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs. Cell stem cell 18, 541-553, doi : 10.1016/j.stem.2016.01.22. 2016.

27) Ying, Q. L. et al : The ground state of embryonic stem cell self-renewal. Nature 453, 519-523, doi : nature06968 [pii] 10.1038/nature06968. 2008.

28) Tesar, P. J. et al : New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448, 196-199. 2007.
pubmed

29) Greber, B. et al : Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cells. Cellstem cell 6, 215-226, doi : 10.1016/j.stem2010.01.003. 2010.

30) Nichols, J. & Smith, A. Naive and primed pluripotent states. Cell stem cell 4, 487-492, doi : 10.1016/j.stem2009.05.015. 2009.

31) Nichols, J. & Smith, A. Pluripotency in the embryo and in culture. Cold Spring Harb Perspect Biol 4, a008128, doi : 10.1101/cshperspect.a008128. 2012.

32) Hanna, J. et al : Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci U S A 107, 9222-9227, doi : 1004584107 [pii] 10.1073/pnas.1004584107. 2010.

33) Gafni, O. et al : Derivation of novel human ground state naive pluripotent stem cells. Nature 504, 282-286, doi : 10.1038/naturel2745. 2013.

34) Theunissen, T. W. et al. Systematic identification of culture conditions for induction and maintenance of naive human pluripotency. Cell stem cell 15, 471-487, doi : 10.1016/j.stem.2014.07.002. 2014.

35) Ware, C. B. et al : Derivation of naive human embryonic stem cells. Proc Natl Acad Sci U S A 111, 4484-4489, doi : 10.1073/pnas.1319738111 (2014).

36) Chan, Y. S. et al : Induction of a human pluripotent state with distinct regulatory circuitry that resembles preimplantation epiblast. Cell stem cell 13, 663-675, doi : 10.1016/j.stem.2013.11.015. 2013.

37) Takashima, Y. et al : Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell 158, 1254-1269, doi : 10.1016/j.cell.2014.08.029. 2014.

P.13 掲載の参考文献

1) Langer R, Vacanti JP : Science. 1993 May14 ; 260 (5110) : 920-6. Tissue engineering.

2) Masumoto H, Ikuno T, Takeda M, Fukushima H, Marui A, Katayama S, Shimizu T, Ikeda T, Okano T, Sakata R, Yamashita JK. : Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration. Sci Rep. 20140ct 22 ; 4 : 6716. doi : 10.1038/srep06716.

3) Takehiko Matsuo, Hidetoshi Masumoto, Shuhei Tajima, Takeshi Ikuno, Shiori Katayama, Kenji Minakata, Tadashi Ikeda, Kohei Yamamizu, Yasuhiko Tabata, Ryuzo Sakata, Jun K. Yamashita : Ef6cientlong-termsurvival of cellgraftsaft ermyocardial infarction with thickviablecardiactissueentire ly from pluripotent stem cells Sci Rep. 2015 ; 5 : 16842. Published online 2015 Nov 20. doi : 10.1038/srep16842

4) Sakaguchi K1, Shimizu T, Horaguchi S, Sekine H, Yamato M, Umezu M, Okano T. : In vitro engineering of vascularized tissue surrogates. Sci Rep. 2013 ; 3 : 1316. doi : 10.1038/srep01316.

5) Shimizu T, Sekine H, Yang J, Isoi Y, Yamato M, Kikuchi A, Kobayashi E, Okano T. : Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J. 2006 Apr ; 20 (6) : 708-10. Epub 2006 Jan 26.

6) Manabu Itoh, Koichi Nakayama, Ryo Noguchi, Keiji Kamohara, Kojirou Furukawa, Kazuyoshi Uchihashi, Shuji Toda, Jun-ichi Oyama, Koichi Node, Shigeki Morita : Scaffold-Free Tubular Tissues Created by a Bio-3D Printer Undergo Remodeling and Endothelialization when Implanted in Rat Aortae. PLoS One. 2015 ; 10 (9) : e0136681. Published online 2015 Sep 1. doi : 10.1371/journal.pone.0136681

7) Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T, Zhang RR, Ueno Y, Zheng YW, Koike N, et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature. 2013 ; 499 : 481-4. doi : 10.1038/nature12271

8) Takebe T, Zhang RR, Koike H, Kimura M, Yoshizawa E, Enomura M, Koike N, Sekine K, Taniguchi H. : Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant. Nat Protoc. 2014 Feb ; 9 (2) : 396-409. doi : 10.1038/nprot.2014.020. Epub 2014 Jan 23.

9) Takebe T, Enomura M, Yoshizawa E, Kimura M, Koike H, Ueno Y, Matsuzaki T, Yamazaki T, Toyohara T, Osafune K, Nakauchi H, Yoshikawa HY, Taniguchi H. : Vascularized and Complex Organ Buds from Diverse Tissues via Mesenchymal Cell-Driven Condensation. Cell Stem Cell. 2015 May 7 ; 16 (5) : 556-65. doi : 10.1016/j.stem.2015.03.004. Epub 2015 Apr 16.

P.17 掲載の参考文献

1) H. R. 34-21st Century Cures Act. https://www.congress.gov/bill/114th-congress/house-bill/34

2) 「ヒト又は動物細胞株を用いて製造されるバイオテクノロジー応用医薬品のウイルス安全性評価」について. 医薬審第329号. 平成12年2月22日.

3) 「生物薬品 (バイオテクノロジー応用医薬品/生物起源由来医薬品) 製造用細胞基剤の由来, 調製及び特性解析」について. 医薬審第873号. 平成12年7月14日.

4) 生物由来原料基準の運用について. (薬食審査発1002第1号, 薬食機参発1002第5号), 平成26年10月2日

第2章再生・細胞医療産業の最前線

P.28 掲載の参考文献

1) K. Takahashi, S. Yamanaka, Induction of pluripotent stem cells from mouse embryonic and adult fibrobiast cultures by defined factors, Cell. 126, 663-76 (2006)

2) M. Eirakuら, Self-organizing optic-cup morphogenesis in three-dimensional culture, Nature, 472, 51-56 (2011)

3) Y. Sasai, Next-generation regenerative medicine : organogenesis from stem cells in 3D culture, Cell Stem Cell, 12, 520-530 (2013)

4) M. Mandaiら, Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration, The New England Journal of Medicine, 376, 1038-1046 (2017)

5) S. Kanekoら, A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord, Nature Medicine, 12, 1380-1389 (2006)

6) T. Nakanoら, Self-formation of optic cups and storable stratified neural retina from human ESCs, Cell Stem Cell, 10, 771-785 (2012)

7) A. Kuwaharaら, Generation of a ciliary margin-like stem cell niche from self-organizing human retinal tissue, Nature Communications, 6, 6286 (2015)

8) M. Nakagawaら, A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells, Scientific Reports, 4, 3594 (2014)

9) M. Mandaiら, iPSC-Derived Retina Transplants Improve Vision in rdl End-Stage Retinal-Degeneration Mice, Stem Cell Reports, 8, 69-83 (2017)

10) H. Shiraiら, Transplantation of human embryonic stem cell-derived retinal tissue in two primate models of retinal degeneration, Proc Natl Acad Sci U S A, 113, E81-90 (2015)

P.34 掲載の参考文献

1) Cultured peribulbar dermal sheath cells can induce hair follicle development and contribute to the dermal sheath and dermal papilla. McElwee KJ, Kissling S, Wenzel E, Huth A, Hoffmann R. J Invest Dermatol. 2003 Dec ; 121 (6) : 1267-75.

P.46 掲載の参考文献

1) Longo, D. L, Rockey, D. C. Bell, P. D. & Hill, J. a. Fibrosis-A Common Pathway to Organ Injury and Failure. N. Engl. J. Med. 372, 1138-1149, 2015.

2) Mueller, M. M. & Fusenig N. E. Friends or foes-bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4, 839-49, 2004.
pubmed

3) Tissue, P. et al. An Immunohistochemical Method for Identifying Fibroblasts in The Journal of Histochemistry & Cytochemistry. J Histochem. Cytochem. 56, 347-358, 2008.

4) Kong P., Christia, P., Saxena, A., Su, Y. & Frangogiannis, N. G. Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis. Am. J. Physiol. -Hear. Circ. Physiol. 305, H1363-H1372, 2013.

5) Goldsrnith, E. C. et al. Organization of fibroblasts in the heart. Dev. Dyn. 230, 787-794, 2004.

6) Chang, H. Y. et al, Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc. Natl. Acad. Sci 99, 12877-12882, 2002.
pubmed

7) Ivey, M. J. & Tallquist, M. D. Defining the Cardiac Fibroblast. Circ. J. 80, 2016.
pubmed

8) Shimoji, K. et al. G-CSF Promotes the Proliferation of Developing Cardiomyocytes In Vivo and in Derivation from ESCs and iPSCs. Cell Stem Cell 6, 227-237, 2010.
pubmed

9) Ieda, M. et al. Cardiac Fibroblasts Regulate Myocardial Proliferation through B1 Integrin Signaling. Dev. Cell 16, 233-244, 2009.

10) Engel, F. B., Hsieh, P. C. H., Lee, R. T. & Keating, M. T. FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc. Natl. Acad. Sci. U. S. A. 103, 15546-15551, 2006.

11) Bock-Marquette, I., Saxena, A., White, M. D., Michael DiMaio, J. & Srivastava, D. Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432, 466-472, 2004.

12) Helix Biotherapeutic Delivery. Available at : http://www.biocardia. com/product_pipeline/helix.shtml.

13) Cardio3 BioSciences Announces CE Marking for its C-Cath (R) Injection Catheter. Available at : http://www.celyad.com/news/cardio3-biosciences-announces-ce-marking-for-its-c-cath-injection-catheter.

14) Behfar, A. et al. Optimized Delivery System Achieves Enhanced Endomyocardial Stem Cell Retention. Circ. Cardiovasc. Interv. 6, 710-718, 2013.
pubmed

P.51 掲載の参考文献

1) 高木大輔. 瀬尾学. 宮岡敦史, 安部美樹子, 鴨野俊平, "iPS細胞由来細胞を用いた3次元組織体構築-自動コーティング技術と評価技術". リコーテクニカルレポート No. 41, pp. 118-127 (2016). (https://jp.ricoh.com/technology/techreport/41/pdf/RTR41a14.pdf)

2) 乾賢一監修, バイオ医薬品と再生医療. 臨床薬学テキストシリーズ, (株) 中山書店, 2016.

3) 新井健生編, 3次元細胞システム設計論, 組織工学ライブラリ, (株) コロナ社, 2016.

4) 大和雅之編, 細胞社会学, 組織工学ライブラリ. (株) コロナ社, 2016.

5) M. Matsusaki, K. Kadowaki, Y. Nakahara, M. Akashi, Fabrivation of Cellular Multilayers with Nanometer-Sized Extracellulai Matrix Films, Angew. Chem. Int. Ed., Vol. 46, No. 25, pp. 4689-4692 (2007).

はじめての方へ

個人／法人会員登録のご案内